Across TCGA patient cohorts, FAM162B mutation is significantly associated with the RNA expression of many other genes, with 34 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible FAM162B-associated genes across cancer lineages are TRAJ22, RN7SL539P, and TBC1D26-AS1. Each is linked with FAM162B in more than 1 cancer types. Because this analysis shows association rather than direction, both FAM162B-to-partner and partner-to-FAM162B results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (FAM162B→partner) and Y-score (partner→FAM162B) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	TRAJ22 →	+1.347	+4.181	<.001	.009	3	2
BRCA	RN7SL539P →	+0.079	+8.471	<.001	.005	3	1
COAD	TBC1D26-AS1 →	+0.208	+4.209	<.001	.009	3	1
COAD	RN7SL835P →	+0.522	+5.868	<.001	<.001	3	1
BRCA	RNU4ATAC7P →	+0.278	+8.055	<.001	.007	3	1
UCEC	CTHRC1P1 →	+0.157	+4.279	<.001	.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 34 associations by consensus.

Exploration

FAM162B survival (RNA) · tumor vs normal (RNA) · all FAM162B data types